Stock Market News3 hours Bristol-Myers: Still An Opportunity Yielding Over 4% Seeking Alpha
Bristol-Myers: Still An Opportunity Yielding Over 4%.
X3 hours Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know Zacks
X2 days Jefferies Upgrades Bristol Myers Squibb to ‘buy’ on drug Cobenfy Investing.com
X2 days BMY vs. VRTX: Which Stock Is the Better Value Option? Zacks
X5 days Bristol Myers Squibb (BMY) Stock Moves -0.89%: What You Should Know Zacks
X1 week Bristol Myers Stock Surges 36.5% in Six Months: Time to Buy or Sell? Zacks
X1 week Bristol Myers (BMY) Upgraded to Buy: Here’s Why Zacks
X1 week Is Bristol Myers Squibb (BMY) a Great Value Stock Right Now? Zacks
X2 weeks Analyst Report: Bristol-Myers Squibb Co. Yahoo Finance
X2 weeks Bristol-Myers Squibb Company (BMY) Citi’s 2024 Global Healthcare Conference (Transcript) Seeking Alpha
X2 weeks Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know Zacks
X2 weeks Is Bristol-Myers Squibb Stock a Millionaire Maker? Yahoo Finance
X3 weeks Calls of the Day: Martin Marietta, Datadog, Bristol-Myers, Eli Lilly and Disney YouTube
X3 weeks Prime Medicine’s Bristol Myers Partnership Boosts Outlook For Gene Editing Therapies Seeking Alpha
X3 weeks 5 Reasons Bristol-Myers Squibb Looks Good Now (Rating Upgrade) Seeking Alpha
X4 weeks AbbVie Jumps 5% On An Upgrade Despite Bristol Myers-Tied Setback Investor's Business Daily
X4 weeks Replimune Stock Rallies on BLA Filing for Melanoma Combo Drug Zacks
X4 weeks Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It Zacks
X4 weeks Bristol-Myers Squibb Company (BMY) Jefferies London Healthcare Conference (Transcript) Seeking Alpha
X1 month Bristol-Myers Squibb: Buy This Bargain Before It’s Gone Seeking Alpha
X1 month Bristol-Myers Squibb Company (BMY) Guggenheim Securities Inaugural Healthcare Innovation Conference (Transcript) Seeking Alpha
X1 month Bristol Myers Stock Trading Near 52-Week High: Time to Buy or Sell? Zacks
X1 month Bristol Rockets 11% As Investors Question AbbVie’s $8.7 Billion ‘Mistake’ Investor's Business Daily
X2 months Bristol Myers Squibb Stock Gets Relative Strength Rating Upgrade Investor's Business Daily
X2 months Bristol-Myers Tops Q3 Earnings and Sales Estimates, Ups 2024 EPS View Zacks
X2 months Bristol Myers Screams To A Year-High After Walloping Profit Expectations Investor's Business Daily
X2 months Pallas Capital Advisors LLC Purchases 9,537 Shares of Bristol-Myers Squibb (NYSE:BMY) MarketBeat
X2 months Wealth Enhancement Advisory Services LLC Cuts Stake in Bristol-Myers Squibb (NYSE:BMY) MarketBeat
X2 months Should Bristol Myers Stock Be in Your Portfolio Pre-Q3 Earnings? Zacks
X2 months Bristol-Myers Squibb Deserves Its Place Among Its Big Pharma Brethren Seeking Alpha
X2 months Allspring Global Investments Holdings LLC Has $11.12 Million Stake in Bristol-Myers Squibb (NYSE:BMY) MarketBeat
X2 months Bristol Myers Squibb’s Q3 Earnings Are Likely To Be Strong Seeking Alpha
X2 months Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know Zacks
X2 months Impact Partnership Wealth LLC Takes Position in Bristol-Myers Squibb (NYSE:BMY) MarketBeat
X2 months Leerink Partnrs Issues Pessimistic Forecast for BMY Earnings MarketBeat
X2 months FY2028 Earnings Estimate for BMY Issued By Leerink Partnrs MarketBeat
X2 months Sequoia Financial Advisors LLC Has $7.40 Million Position in Bristol-Myers Squibb (NYSE:BMY) MarketBeat
X2 months Bristol Myers (BMY) Upgraded to Buy: Here’s What You Should Know Zacks
X2 months BMY or VRTX: Which Is the Better Value Stock Right Now? Zacks
X2 months Raleigh Capital Management Inc. Has $2.20 Million Holdings in Bristol-Myers Squibb (NYSE:BMY) MarketBeat
X2 months Commonwealth Equity Services LLC Decreases Position in Bristol-Myers Squibb (NYSE:BMY) MarketBeat
XThe Stock Market News
TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.